DRTS
Alpha Tau Medical Ltd.NASDAQHealthcare$6.92+0.00%ClosedMarket Cap: $609.0M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
7.59
P/S
0.00
EV/EBITDA
-14.42
DCF Value
$-0.02
FCF Yield
-5.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-57.3%
ROA
-40.0%
ROIC
17.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | NaN% | $-12.6M | $-12.1M | $-0.14 | — |
| FY 2025 | $0.00 | -Infinity% | $-42.3M | $-42.6M | $-0.53 | — |
| Q3 2025 | $0.00 | NaN% | $48.6M | $-11.7M | $-0.14 | — |
| Q2 2025 | $0.00 | NaN% | $-9.6M | $-10.1M | $-0.13 | — |
| Q1 2025 | $0.00 | NaN% | $-9.3M | $-8.7M | $-0.12 | — |
| Q4 2024 | $0.00 | NaN% | $-10.3M | $-9.5M | $-0.14 | — |
| FY 2024 | $0.00 | -Infinity% | $-36.0M | $-31.8M | $-0.45 | — |
| Q3 2024 | $0.00 | NaN% | $-8.3M | $-6.9M | $-0.10 | — |
| Q2 2024 | $0.00 | NaN% | $-9.1M | $-7.4M | $-0.11 | — |
| Q1 2024 | $0.00 | NaN% | $-8.4M | $-8.0M | $-0.11 | — |
| Q4 2023 | $0.00 | -Infinity% | $-9.9M | $-7.4M | $-0.11 | — |
| FY 2023 | $0.00 | -Infinity% | $35.7M | $-29.2M | $-0.42 | — |